Quick Answer
PLUS THERAPEUTICS, INC. reported Long-Term Debt of $3.79 million for fiscal year 2022.
PLUS THERAPEUTICS, INC. Long-Term Debt — Annual History
| Fiscal Year | Long-Term Debt | YoY Change |
|---|---|---|
| 2022 | $3.79M | -24.4% |
| 2021 | $5.00M | — |
Quarterly Long-Term Debt
| Quarter Ending | Long-Term Debt | YoY | QoQ |
|---|---|---|---|
| December 31, 2022 | $3.79M | -24.4% | -7.8% |
| September 30, 2022 | $4.11M | — | -7.0% |
| June 30, 2022 | $4.42M | — | -6.3% |
| March 31, 2022 | $4.72M | — | -5.7% |
| December 31, 2021 | $5.00M | — | — |
- PLUS THERAPEUTICS, INC. showed a decrease of -24.4% in Long-Term Debt compared to the prior fiscal year.
- Over the 2021–2022 period, PLUS THERAPEUTICS, INC.’s long-term debt has declined by 24.4% (from $5.00 million to $3.79 million).
- The most recent figure is from PLUS THERAPEUTICS, INC.’s fiscal year 2023 report (Form 10-K), filed with the SEC on March 5, 2024.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: